Biopharmaceutical firm Cell Therapeutics Inc. (NASDAQ: CTIC) announced a secondary offering this morning of 60,000 shares of its Series 17 preferred stock at a price of $1,000.00 per share: Each share of Series 17…
Sarepta Therapeutics Inc. (NASDAQ: SRPT) is a company which many biohealth and biotech investors have likely never heard of. At least before today. How many shares rise more than 150% when there is not a…
The fiscal cliff has been described as a potential disaster for the finances of individuals and corporations alike. If Congress and the White House do not reach an agreement on the budget and tax…
With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short interest changes from September 14 settlement date versus the August 31 settlement date. Short…
Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) fell about 80% yesterday after the company revealed that there were discrepancies in the data reported on the company’s Phase II trial of its lung-cancer drug bavituximab. That was…
Just over two weeks ago Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM) reported a statistically significant improvement in the company’s bavituximab lung-cancer treatment. Shares jumped nearly 50% and eventually posted at more than two-year high. It’s…
Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) is a situation that has gone from bad to worse. Last week there was a huge drop on the news Aetna Inc. (NYSE: AET) was altering its reimbursement coverage,…
U.S. drugmaker Vivus Inc. (NASDAQ: VVUS) announced this morning that the company had been notified that its anti-obesity drug, Qsiva, is not likely to be approved for use in the European Union. The company…
Questcor Pharmaceuticals Inc. (NASDAQ: QCOR) has seen a sudden and rapid share price tank today. Reports are out that Aetna Inc. (NYSE: AET) has managed to stop payments to the company. Details are still outstanding,…
Everyone knows that many Americans are fat — among the fattest people in world. And nearly everyone knows that Americans are getting fatter. It is an epidemic that ruins the health of many overweight people…
The United States has seen its share of tension and protests over Chinese efforts to make acquisitions in North America, but usually this is over oil and gas assets. So what is there to…
Vical Inc. (NASDAQ: VICL) is seeing its shares surging higher on news that it has signed a worldwide, nonexclusive licensing pact with drug giant Bristol-Myers Squibb Co. (NYSE: BMY). The pact covers Vical’s patented…
The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date versus the August 15 settlement date. We have tracked the key short interest changes…
Geron Corp. (NASDAQ: GERN) has spent much of the past decade migrating from the key stem cell research player into a total dud. Now we have more news that may act as a further…
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) is surging on news updating its non-small cell lung cancer trial. The company said that interim results were presented from its 121 patient randomized, double-blind, placebo-controlled Phase IIb trial in patients…